Officials expected to offer 2nd booster shot for those over 50 years old

Pfizer and Moderna asked the FDA last week to authorize another booster dose.

March 27, 2022, 7:13 PM

As soon as Tuesday, the U.S. Food and Drug Administration could authorize COVID-19 booster shots for Americans over 50 years old, two officials familiar with the matter told ABC News, though the fourth shots are likely to be only offered and not formally recommended.

The officials stressed that the details are still under discussion and could change in the next few days.

After FDA's expected authorization early this week, the Centers for Disease Control and Prevention will give guidance on how to implement it in pharmacies and doctors offices around the country, as the process has gone throughout the pandemic.

The language from CDC Director Rochelle Walensky is expected to be that people over 50 may get a second booster shot, rather than should get a second booster shot, officials said.

PHOTO: (FILES) In this file photo taken on January 12, 2022 a nurse prepares a dose of a Pfizer/BioNTech vaccine against the coronavirus disease Covid-19 in a social center of La Gavotte Peyret popular neighbourhood, in Septeme-Les-Vallons.
(FILES) In this file photo taken on January 12, 2022 a nurse prepares a dose of a Pfizer/BioNTech vaccine against the coronavirus disease Covid-19 in a social center of La Gavotte Peyret popular neighbourhood, in Septeme-Les-Vallons, near Marseille. - French Prime Minister announced on March 12, 2022 the opening of the fourth dose of vaccine "to the over 80s who have received their booster dose for more than three months", in the face of the slight rebound in the Covid epidemic, in an interview with Le Parisien.
Clement Mahoudeau/AFP via Getty Images

In other words, the shots would be available for people to make individual decisions based on their health, risk tolerance and age. In the past, the CDC has used similar language to open up booster shots first to the most vulnerable and then to the general population.

FDA's panel of experts will convene on April 6 to discuss the broader population and what population will need booster shots next, as well as the need for a variant-specific booster.

Officials weighing the decision are also considering that anyone who gets a booster this spring would likely get boosted again when they are recommended for the broader public later this year, potentially in the fall, according to another person familiar with the matter.

Pfizer and Moderna asked the FDA last week to authorize another booster dose -- especially for elderly Americans, a group that tends to have weaker immune protection.

Pfizer asked the FDA to authorize fourth doses for people older than 65, while Moderna asked for authorization for everyone 18 and older.

ABC News' Sony Salzman contributed to this report.

Related Topics

ABC News Live

ABC News Live

24/7 coverage of breaking news and live events